Latest Insider Transactions at Karuna Therapeutics, Inc. (KRTX)
This section provides a real-time view of insider transactions for Karuna Therapeutics, Inc. (KRTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Karuna Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Karuna Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 02
2022
|
Andrew Craig Miller President of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
750
+1.42%
|
$3,750
$5.1 P/Share
|
|
Dec 01
2022
|
Andrew Craig Miller President of R&D |
SELL
Open market or private sale
|
Direct |
15,000
-57.14%
|
$3,420,000
$228.3 P/Share
|
|
Nov 15
2022
|
Troy A. Ignelzi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
16,500
-62.33%
|
$3,712,500
$225.85 P/Share
|
|
Nov 15
2022
|
Troy A. Ignelzi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,500
+38.4%
|
$148,500
$9.2 P/Share
|
|
Nov 11
2022
|
Andrew Craig Miller President of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+2.44%
|
$10,000
$5.1 P/Share
|
|
Nov 10
2022
|
Andrew Craig Miller President of R&D |
SELL
Open market or private sale
|
Direct |
15,000
-37.04%
|
$3,375,000
$225.98 P/Share
|
|
Nov 09
2022
|
Stephen K. Brannan Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-25.0%
|
$1,080,000
$216.0 P/Share
|
|
Nov 09
2022
|
Stephen K. Brannan Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+20.0%
|
$45,000
$9.2 P/Share
|
|
Nov 03
2022
|
Andrew Craig Miller President of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+3.6%
|
$4,000
$2.92 P/Share
|
|
Nov 01
2022
|
Andrew Craig Miller President of R&D |
SELL
Open market or private sale
|
Direct |
15,000
-28.04%
|
$3,375,000
$225.08 P/Share
|
|
Oct 11
2022
|
Laurie J Olson |
SELL
Open market or private sale
|
Direct |
1,000
-100.0%
|
$205,000
$205.63 P/Share
|
|
Oct 11
2022
|
Laurie J Olson |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+50.0%
|
$84,000
$84.86 P/Share
|
|
Oct 10
2022
|
Stephen K. Brannan Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-25.0%
|
$1,035,000
$207.51 P/Share
|
|
Oct 10
2022
|
Stephen K. Brannan Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+20.0%
|
$45,000
$9.2 P/Share
|
|
Oct 04
2022
|
Troy A. Ignelzi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
400
-3.86%
|
$93,200
$233.2 P/Share
|
|
Oct 03
2022
|
Troy A. Ignelzi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,100
-10.45%
|
$947,100
$231.11 P/Share
|
|
Sep 30
2022
|
Troy A. Ignelzi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,500
-12.24%
|
$2,404,500
$229.01 P/Share
|
|
Sep 09
2022
|
Stephen K. Brannan Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-25.0%
|
$1,215,000
$243.46 P/Share
|
|
Sep 09
2022
|
Stephen K. Brannan Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+20.0%
|
$35,000
$7.27 P/Share
|
|
Aug 15
2022
|
Laurie J Olson |
SELL
Open market or private sale
|
Direct |
1,000
-100.0%
|
$267,000
$267.59 P/Share
|
|
Aug 15
2022
|
Laurie J Olson |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+50.0%
|
$84,000
$84.86 P/Share
|
|
Aug 09
2022
|
Troy A. Ignelzi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
16,500
-39.79%
|
$3,745,500
$227.83 P/Share
|
|
Aug 09
2022
|
Troy A. Ignelzi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,500
+28.46%
|
$148,500
$9.2 P/Share
|
|
Aug 09
2022
|
Stephen K. Brannan Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
25,000
-34.82%
|
$5,700,000
$228.09 P/Share
|
|
Aug 09
2022
|
Stephen K. Brannan Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+25.61%
|
$175,000
$7.91 P/Share
|
|
Aug 05
2022
|
James Healy |
BUY
Exercise of conversion of derivative security
|
Direct |
32,500
+50.0%
|
$520,000
$16.0 P/Share
|
|
Jul 11
2022
|
Stephen K. Brannan Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
15,000
-50.0%
|
$1,995,000
$133.29 P/Share
|
|
Jul 11
2022
|
Stephen K. Brannan Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+33.33%
|
$135,000
$9.2 P/Share
|
|
Jun 30
2022
|
James Healy |
BUY
Open market or private purchase
|
Indirect |
72,223
+1.72%
|
$8,811,206
$122.83 P/Share
|
|
Jun 29
2022
|
James Healy |
BUY
Open market or private purchase
|
Indirect |
47,777
+0.6%
|
$5,876,571
$123.67 P/Share
|
|
Jun 09
2022
|
Stephen K. Brannan Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-25.0%
|
$550,000
$110.9 P/Share
|
|
Jun 09
2022
|
Stephen K. Brannan Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+20.0%
|
$45,000
$9.2 P/Share
|
|
May 31
2022
|
Steven M Paul |
BUY
Bona fide gift
|
Indirect |
106,485
+50.0%
|
-
|
|
May 31
2022
|
Steven M Paul |
SELL
Bona fide gift
|
Indirect |
106,485
-100.0%
|
-
|
|
May 27
2022
|
Steven M Paul |
BUY
Bona fide gift
|
Indirect |
106,485
+50.0%
|
-
|
|
May 27
2022
|
Steven M Paul |
SELL
Bona fide gift
|
Indirect |
106,485
-100.0%
|
-
|
|
May 27
2022
|
Laurie J Olson |
SELL
Open market or private sale
|
Direct |
1,000
-100.0%
|
$110,000
$110.0 P/Share
|
|
May 27
2022
|
Laurie J Olson |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+50.0%
|
$84,000
$84.86 P/Share
|
|
May 09
2022
|
Stephen K. Brannan Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-25.0%
|
$520,000
$104.1 P/Share
|
|
May 09
2022
|
Stephen K. Brannan Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+20.0%
|
$45,000
$9.2 P/Share
|
|
Apr 21
2022
|
Troy A. Ignelzi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
40
-0.16%
|
$5,360
$134.46 P/Share
|
|
Apr 21
2022
|
Troy A. Ignelzi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40
+0.16%
|
$360
$9.2 P/Share
|
|
Apr 20
2022
|
Troy A. Ignelzi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
704
-2.74%
|
$93,632
$133.2 P/Share
|
|
Apr 20
2022
|
Troy A. Ignelzi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
704
+2.67%
|
$6,336
$9.2 P/Share
|
|
Apr 19
2022
|
Troy A. Ignelzi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,500
-12.29%
|
$455,000
$130.81 P/Share
|
|
Apr 19
2022
|
Troy A. Ignelzi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+10.95%
|
$31,500
$9.2 P/Share
|
|
Apr 01
2022
|
James Healy |
BUY
Open market or private purchase
|
Indirect |
47
+6.44%
|
$6,063
$129.38 P/Share
|
|
Apr 01
2022
|
Stephen K. Brannan Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,728
-34.0%
|
$989,184
$128.45 P/Share
|
|
Apr 01
2022
|
Stephen K. Brannan Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,228
+19.83%
|
$61,368
$6.36 P/Share
|
|
Mar 01
2022
|
Stephen K. Brannan Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,728
-38.2%
|
$826,896
$107.38 P/Share
|